This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Hsc Research and Development Limited Partnership, Medical Research Council. Active years: 2000-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2000-2003
Title: The Innovations of James Ellis
Introduction
James Ellis is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of molecular biology, particularly in the development of hybrid nucleic acid molecules. With a total of 2 patents to his name, Ellis has demonstrated a commitment to advancing scientific knowledge and technology.
Latest Patents
Among his latest patents is the invention titled "Hybrid nucleic acid molecules and vectors including β-globin regulatory elements." This invention encompasses a locus control subregion that possesses chromatin opening domain activity. The activity confers reproducible activation of tissue-specific expression on a linked transgene to a non-physiological level when the transgene is integrated in single copy in the genome of a host cell. This innovative work has the potential to impact various applications in genetic research and therapy.
Career Highlights
Throughout his career, James Ellis has worked with esteemed organizations such as the Medical Research Council and HSC Research and Development Limited Partnership. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
James Ellis has had the opportunity to work alongside notable colleagues, including Franklin Gerardus Grosveld and Dimitris Kioussis. These collaborations have further enriched his research and innovation efforts.
Conclusion
James Ellis is a distinguished inventor whose work in hybrid nucleic acid molecules has made a significant impact in the field of molecular biology. His contributions continue to inspire advancements in genetic research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile